Aim: Effective cancer treatment relies on intravenous chemotherapy penetrating the entire tumour in sufficient concentrations, which is largely reliant on effective blood supply into and within the tumour. However, tumours contain abnormal vasculature with inefficient blood perfusion leading to the inability for chemotherapy to reach the target tumour [1]. Pre-clinical evidence suggests acute exercise may increase blood flow by 200% [2]. However, most pre-clinical studies investigate the effects of light-to-moderate intensity exercise and subsequently there is little evidence regarding the most effective exercise intensity for improved tumour vasculature. Therefore, the aim of this ongoing case series is to determine whether exercise changes tumour blood flow in a clinical model using non-invasive techniques, and how exercise intensity effects degree of change in blood flow to tumours in patients with liver metastases.
Methods: Participants were eligible if they were aged over 18 years, had stage IV cancer with liver metastasis and ECOG 0-2. The study visit consisted of an aerobic fitness test (YMCA) to determine cardiorespiratory fitness and three 5-minute bouts of exercise at low, moderate and high intensities. After each exercise bout, Doppler ultrasound was used to measure a liver tumour vessel and the hepatic artery (as a control) to determine blood flow parameters.
Results: Exercise increased peak systolic velocities (PSV) to liver tumours at all intensities compared to rest. Moderate and high exercise intensities showed a marked increase in PSV within the first 2 minutes after exercise. The hepatic artery showed less variability in PSV with time compared to the liver tumour. Cardiorespiratory fitness did not affect tumour PSV.
Conclusion: The results of this case series thus far suggest that exercise increases tumour blood flow at all exercise intensities with particular emphasis on moderate and high intensities. This supports the potential for using exercise as an adjunct to standard treatment to improve chemotherapy efficacy.